11-11-2008: Alfonso Camba appointed VP Manufacturing Operations of Cellerix
27-10-2008: Debjani Roy, new Director of Intellectual Property of Cellerix
21-10-2008: Ontaril® closer to the market
Cellerix ends the recruitment for the first Phase III trial
It is sticking to the planned schedule, which is expected to be commercialized by 2011
13-10-2008: Joël Jean-Mairet to become Chairman of Cellerix
Eduardo González appointed Director.
1-10-2008: Cellerix obtains a 10M€ debt facility with ETV Capital
The biopharmaceutical company will be able to finalize clinical development of Ontaril®, its treatment for Perianal Fistulas for Crohn and non-Crohn patients.